Optimizing Pain Control in Transurethral Resection of the Prostate
NCT ID: NCT04102566
Last Updated: 2019-09-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE4
50 participants
INTERVENTIONAL
2017-12-08
2019-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Nalbuphine as an Adjuvant to Subarachnoid Block on Postoperative Analgesia in TURP Surgery
NCT06153602
Pre-operative Education Modalities to Decrease Opioid Use
NCT04933084
Use of Pedometer Following Radical Prostatectomy
NCT04206280
Total Intravenous Anaesthesia (TIVA) Versus Spinal Anaesthesia in Patients Undergoing Transurethral Prostate Resection
NCT01118260
Intrathecal Morphine in Robot-assisted Prostatectomy
NCT01991275
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard of care arm
The standard of care group will group will receive the following regimen while inpatient:
* 2% topical lidocaine gel applied to catheter tip as needed for pain, maximum dose of 600mg in 12 hours
* Acetaminophen 1000mg every 8 hours standing
* Oxycodone 5mg PO every 4 hours as needed pain
* Phenazopyridine 100mg TID as needed for urinary burning
* Senna 1 tab every 12 hours
* Miralax 17g powder once daily as needed for constipation
The standard of care group will get the following prescriptions on discharge:
* Oxycodone 5mg every 4 hours as needed pain - 15 tabs
* Acetaminophen 1000mg every 8 hours standing for two days then as needed
* Phenazopyridine 100mg TID as needed for urinary burning - 9 tabs
* Senna 1 tab every 12 hours - 10 tabs
No interventions assigned to this group
Multi-modal group
The multi-modal group will receive the following regimen while inpatient:
* 2% topical lidocaine gel applied to catheter tip as needed for pain, maximum dose of 600mg in 12 hours
* Acetaminophen 1000mg every 8 hours standing
* Ibuprofen 600mg every 6 hours standing
* Oxycodone 5mg PO every 4 hours as needed pain
* Phenazopyridine 100mg TID as needed for urinary burning
* Senna 1 tab every 12 hours
* Miralax 17g powder once daily as needed for constipation
* Patient Education (Figures 2 \& 3)
The multi-modal group will receive the following prescriptions on discharge:
* Acetaminophen 1000mg every 8 hours standing for two days then as needed - 30 tabs
* Ibuprofen 600mg every 8 hours standing for two days then as needed - 30 tabs
* Phenazopyridine 100mg TID as needed for urinary burning - 9 tabs
* Senna 1 tab every 12 hours - 10 tabs
Ibuprofen 600 mg
We'll be adding ibuprofen while trying to limit oxycodone use while hospitalized. Patients will not be discharged with a narcotic.
Education
We'll be adding education to patient's post-operative instructions to aid in their pain control management.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ibuprofen 600 mg
We'll be adding ibuprofen while trying to limit oxycodone use while hospitalized. Patients will not be discharged with a narcotic.
Education
We'll be adding education to patient's post-operative instructions to aid in their pain control management.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Are 18 years of age or greater
* Are proficient in English
Exclusion Criteria
* Have an allergy to a medication included in the protocol
* Have a history of pelvic radiation
* Have renal failure (Serum Cr \> 2.0 mg/dl), peptic ulcer disease, history of gastric bypass, cirrhosis, or other contraindication precluding use of NSAID's
* Have liver failure, hepatitis, or alcohol abuse which precludes use of acetaminophen
18 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Virginia Mason Hospital/Medical Center
OTHER
Benaroya Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Una Lee
Principal Investigator and Attending urologist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Virginia Mason Medical Center
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Alam A, Gomes T, Zheng H, Mamdani MM, Juurlink DN, Bell CM. Long-term analgesic use after low-risk surgery: a retrospective cohort study. Arch Intern Med. 2012 Mar 12;172(5):425-30. doi: 10.1001/archinternmed.2011.1827.
Sun EC, Darnall BD, Baker LC, Mackey S. Incidence of and Risk Factors for Chronic Opioid Use Among Opioid-Naive Patients in the Postoperative Period. JAMA Intern Med. 2016 Sep 1;176(9):1286-93. doi: 10.1001/jamainternmed.2016.3298.
Hill MV, Stucke RS, McMahon ML, Beeman JL, Barth RJ Jr. An Educational Intervention Decreases Opioid Prescribing After General Surgical Operations. Ann Surg. 2018 Mar;267(3):468-472. doi: 10.1097/SLA.0000000000002198.
Hill MV, McMahon ML, Stucke RS, Barth RJ Jr. Wide Variation and Excessive Dosage of Opioid Prescriptions for Common General Surgical Procedures. Ann Surg. 2017 Apr;265(4):709-714. doi: 10.1097/SLA.0000000000001993.
Kose O, Saglam HS, Altun ME, Sonbahar T, Kumsar S, Adsan O. Prilocaine irrigation for pain relief after transurethral resection of the prostate. J Endourol. 2013 Jul;27(7):892-5. doi: 10.1089/end.2013.0001. Epub 2013 Jun 12.
American Society of Anesthesiologists Task Force on Acute Pain Management. Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology. 2012 Feb;116(2):248-73. doi: 10.1097/ALN.0b013e31823c1030. No abstract available.
Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016. JAMA. 2016 Apr 19;315(15):1624-45. doi: 10.1001/jama.2016.1464.
Maughan BC, Hersh EV, Shofer FS, Wanner KJ, Archer E, Carrasco LR, Rhodes KV. Unused opioid analgesics and drug disposal following outpatient dental surgery: A randomized controlled trial. Drug Alcohol Depend. 2016 Nov 1;168:328-334. doi: 10.1016/j.drugalcdep.2016.08.016. Epub 2016 Sep 20.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB17-098
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.